Growth Metrics

GeneDx Holdings (WGS) Non-Current Deferred Tax Liability (2021 - 2026)

GeneDx Holdings has reported Non-Current Deferred Tax Liability over the past 6 years, most recently at $1.4 million for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 21.77% to $1.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Mar 2026, up 21.77% year-over-year, with the annual reading at $757000.0 for FY2025, 21.55% down from the prior year.
  • Non-Current Deferred Tax Liability was $1.4 million for Q1 2026 at GeneDx Holdings, up from $757000.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $56.5 million in Q4 2023 and troughed at $747000.0 in Q2 2025.
  • The 5-year median for Non-Current Deferred Tax Liability is $1.4 million (2024), against an average of $8.1 million.
  • Year-over-year, Non-Current Deferred Tax Liability skyrocketed 2024.03% in 2023 and then plummeted 98.29% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.7 million in 2022, then skyrocketed by 2024.03% to $56.5 million in 2023, then plummeted by 98.29% to $965000.0 in 2024, then dropped by 21.55% to $757000.0 in 2025, then skyrocketed by 85.47% to $1.4 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Non-Current Deferred Tax Liability are $1.4 million (Q1 2026), $757000.0 (Q4 2025), and $1.0 million (Q3 2025).